BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17054145)

  • 1. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001877. PubMed ID: 17054145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001877. PubMed ID: 21249649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001877. PubMed ID: 19821284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for breast cancer with mammography.
    Gøtzsche PC; Jørgensen KJ
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001877. PubMed ID: 23737396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for breast cancer with mammography.
    Olsen O; Gøtzsche PC
    Cochrane Database Syst Rev; 2001; (4):CD001877. PubMed ID: 11687128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
    Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
    J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer screening with mammography: overview of Swedish randomised trials.
    Nyström L; Rutqvist LE; Wall S; Lindgren A; Lindqvist M; Rydén S; Andersson I; Bjurstam N; Fagerberg G; Frisell J
    Lancet; 1993 Apr; 341(8851):973-8. PubMed ID: 8096941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
    Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
    Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits and harms of breast cancer screening: an independent review.
    Independent UK Panel on Breast Cancer Screening
    Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
    Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.